235 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (41)
- Autoimmune Disorders (1)
- Bone & Muscle (2)
- COVID-19 (Coronavirus) (1)
- Ear, Nose and Throat (8)
- (-) Endocrine & Metabolic Disease (1)
- (-) Eye (2)
- Healthy Volunteers (8)
- Kidney Disease (1)
- Neurological Disorders (12)
- Obesity (2)
- Obstetrics & Gynecology (1)
- Pediatrics (1)
- Psychiatric Disorders (1)
Displaying 1 - 3 of 3
Research Study of New Treatment Called NT-501 (Encapsulated Cell Therapy (ECT) Implant) for Glaucoma
Condition: Eye / Glaucoma
Investigator: George Cioffi, MD
Status: Closed
Glaucoma is a given name of a group of diseases that affect the retinal ganglion cells in the eye and the optic nerve. Glaucoma cause degeneration of the retinal ganglion cells in the retina and their projections (axons) that form the optic nerve. Retinal ganglion cells and their axons transmit all of our vision information from the eye to the brain through…
Condition: Endocrine & Metabolic Disease
Investigator: Judith Korner, MD
Status: Closed
The purpose of these studies is to gain an understanding of the mechanisms that promote weight loss and improved glucose control. The ultimate goal is to identify therapeutic pathways for obesity and diabetes as a way to optimize surgical procedures and discover novel non-surgical targets for safe and effective drug therapy.…
Condition: Eye
Investigator: Stephen Tsang, MD, PhD
Status: Closed
Stargardt macular degeneration isa genetic condition, which in mostcases causes vision loss early in lifeand leads to legal blindness. Thereis currently no FDA-approvedtreatment.This trial will evaluate the safetyand effects of ALK-001, a newpotential drug treatment, on theprogression of…